The Prescription Drug Monitoring Program Training and Technical Assistance Center (PDMP TTAC) reports 2020 data and 2021 features of the Connecticut State PDMP.
Connecticut’s PDMP name is the CT Prescription Monitoring and Reporting System, which is managed by the Department of Consumer Protection, Drug Control Division. The email address is provided, along with website URLs for enrollment, query, data upload, and statistics. Contact information is provided for the PMP Program Manager and the PMP Administrator. For 2020, the state population was 3,608,298, and there were 25.603 registered prescribers and 696 DEA registered dispensers. There are 18 available PDMP reports. Funding sources for the PDMP are the state general fund, a BJA grant, a CDC grant, SAMHSA grant, and a CMS grant. There are four employees for operations, one for technical issues, and one who performs analytical/epidemiological responsibilities. Regarding policies and procedures, key dates in PDMP development are provided, along with referral information for relevant statutes and rules. Miscellaneous capabilities and policies are reported. There is a data retention policy. Training related to the PDMP is available for prescribers, dispensers, and law enforcement. Training is required for law enforcement personnel before PDMP use. Law enforcement access to PDMP data requires an active investigation, a subpoena, or a court order/approval. Law enforcement access is through an online/web portal. Information required for those querying the PDMP is provided. Enrollment in and use of the PDMP is required for drug prescribers. Veterinarians have guidelines for their participation in the PDMP. Data monitored or accessible covers Schedules II-V. The PDMP has the authority to monitor other substances and remove any drugs from monitoring. Technological capabilities are reported. States are listed for which interstate data sharing exists. Patient matching includes a probabilistic match and access to patient matching algorithms. Data are provided on requestors and reports authorized and produced.
Similar Publications
- Opening Remarks by the Honorable James K. Stewart, Director, National Institute of Justice Before the Drug Use Forecasting Advisory Group
- Ensemble Learning to Predict Opioid-related Overdose Using Statewide Prescription Drug monitoring Program and Hospital Discharge Data in the State of Tennessee
- Cuyahoga County, Ohio, Heroin and Crime Initiative: Informing the Investigation and Prosecution of Heroin-Related Overdose, Research Abstract